KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Maxlinear (MXL) EBITDA (2016 - 2026)

Maxlinear has reported EBITDA over the past 17 years, most recently at -$17.2 million for Q1 2026.

  • Quarterly EBITDA rose 62.67% to -$17.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$98.0 million through Mar 2026, up 49.7% year-over-year, with the annual reading at -$126.9 million for FY2025, 43.19% up from the prior year.
  • EBITDA was -$17.2 million for Q1 2026 at Maxlinear, down from -$14.9 million in the prior quarter.
  • Over five years, EBITDA peaked at $51.9 million in Q3 2022 and troughed at -$74.6 million in Q1 2024.
  • The 5-year median for EBITDA is -$17.8 million (2023), against an average of -$13.3 million.
  • Year-over-year, EBITDA skyrocketed 1669.83% in 2022 and then crashed 587.55% in 2024.
  • A 5-year view of EBITDA shows it stood at $41.2 million in 2022, then plummeted by 201.41% to -$41.7 million in 2023, then rose by 1.37% to -$41.2 million in 2024, then surged by 63.83% to -$14.9 million in 2025, then dropped by 15.56% to -$17.2 million in 2026.
  • Per Business Quant, the three most recent readings for MXL's EBITDA are -$17.2 million (Q1 2026), -$14.9 million (Q4 2025), and -$41.3 million (Q3 2025).